Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction

Gastric cancer patients with severe liver dysfunction secondary to hepatic metastases have limited treatment options. Most cytotoxic drugs have a narrow therapeutic index. Although both capecitabine and oxaliplatin have been well tolerated as single agents for patients with severe hepatic dysfunctio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hwang, Seung Jae, Park, Jong Won, Lee, Sehe Dong, Kim, Gyong Jung, Sin, Cheol Ho, Nam, Seung-Hyun, Kim, Bong-Seog
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Association of Internal Medicine 2006
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891032/
https://ncbi.nlm.nih.gov/pubmed/17249509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.4.252
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia